Allergan Plc (AGN)

146.34
NYSE : Health Technology
Prev Close 149.30
Day Low/High 145.84 / 149.61
52 Wk Low/High 125.84 / 197.00
Avg Volume 2.89M
Exchange NYSE
Shares Outstanding 332.61M
Market Cap 49.66B
EPS -15.30
P/E Ratio N/A
Div & Yield 2.96 (1.89%)
Allergan Announces Completion Of Two Positive Safety Studies For Ubrogepant - An Oral CGRP Receptor Antagonist For The Acute Treatment Of Migraine

Allergan Announces Completion Of Two Positive Safety Studies For Ubrogepant - An Oral CGRP Receptor Antagonist For The Acute Treatment Of Migraine

--One-year study continues to support positive safety and tolerability profile for ubrogepant--

FDA Approves Medicines360's SNDA For LILETTA® (levonorgestrel-releasing Intrauterine System) 52 Mg To Prevent Pregnancy For Up To Five Years

FDA Approves Medicines360's SNDA For LILETTA® (levonorgestrel-releasing Intrauterine System) 52 Mg To Prevent Pregnancy For Up To Five Years

DUBLIN and SAN FRANCISCO, Oct. 16, 2018 /PRNewswire/ -- Allergan plc (NYSE:AGN), a leading global pharmaceutical company, and Medicines360, a global nonprofit women's health pharmaceutical company with a mission of expanding access to quality medicines,...

Allergan To Present Data From 13 Abstracts At The 2018 American Society For Dermatologic Surgery Meeting In Phoenix

Allergan To Present Data From 13 Abstracts At The 2018 American Society For Dermatologic Surgery Meeting In Phoenix

DUBLIN, Oct. 11, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, announced today that it will present 13 abstracts at the annual American Society for Dermatologic Surgery (ASDS) meeting in Phoenix, AZ from October...

Allergan Presents New Research At The American College Of Gastroenterology Annual Scientific Meeting (ACG 2018)

Allergan Presents New Research At The American College Of Gastroenterology Annual Scientific Meeting (ACG 2018)

DUBLIN, Oct. 8, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced it will present data from its gastroenterology portfolio at the American College of Gastroenterology Annual Scientific Meeting (ACG),...

Allergan Launches Personalized Study Approach For Clinical Research Programs In Inflammatory Bowel Disease

Allergan Launches Personalized Study Approach For Clinical Research Programs In Inflammatory Bowel Disease

- New programs will evaluate the safety and efficacy of brazikumab (an investigational drug) and the potential correlation between biomarkers and patient outcomes with brazikumab

Allergan Receives FDA Clearance To Treat Area Below The Jawline With CoolSculpting®

Allergan Receives FDA Clearance To Treat Area Below The Jawline With CoolSculpting®

DUBLIN, Oct. 4, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that the CoolSculpting ® treatment received FDA clearance to treat the submandibular area.

Aegon: Transamerica Settles Universal Life Litigation

Aegon: Transamerica Settles Universal Life Litigation

Aegon's subsidiary Transamerica today announces an agreement that would resolve litigation challenging certain monthly deduction rate adjustments on universal life insurance policies in the United States.

Allergan Launches New JUVÉDERM® IT Campaign Designed To Reach The Next Generation Of Consumers

Allergan Launches New JUVÉDERM® IT Campaign Designed To Reach The Next Generation Of Consumers

Bigger, bolder JUVÉDERM® campaign seeks to make JUVÉDERM® a household name for consumers

Allergan To Report Third Quarter 2018 Earnings And Host Conference Call And Webcast

Allergan To Report Third Quarter 2018 Earnings And Host Conference Call And Webcast

DUBLIN, Oct. 1, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that it intends to release third quarter 2018 financial results on Tuesday, October 30, 2018, prior to the open of U.

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Straying from these names could land you in quicksand as the 4th quarter begins.

Allergan And The Allergan Foundation Support Breast Cancer Patients With New Charitable Programs

Allergan And The Allergan Foundation Support Breast Cancer Patients With New Charitable Programs

Allergan Foundation pledges $2,000,000 to support breast health research

Aegon's US Capital Position To Benefit Significantly From Merger Of Legal Entities

Aegon's US Capital Position To Benefit Significantly From Merger Of Legal Entities

Aegon expects a one-time benefit to capital generation of approximately USD 1 billion as a result of the merger of two legal entities.

A Bullish Options Play on Allergan

A Bullish Options Play on Allergan

Buyout rumors aside, AGN is a name I still find attractive.

Aegon Announces Purchase Of Shares To Neutralize 2018 Interim Stock Dividend

Aegon Announces Purchase Of Shares To Neutralize 2018 Interim Stock Dividend

Aegon will repurchase 24,133,950 common shares to neutralize the dilutive effect of the 2018 interim stock dividend.

Allergan CEO: Botox Is in a Very Strong Position, Despite Growing Competition

Allergan CEO: Botox Is in a Very Strong Position, Despite Growing Competition

The entrance of more competition for Botox Cosmetic could expand the market, the drugmaker's top executive says at the Wells Fargo Healthcare Conference in Boston.

US Subsidiaries Aegon Reach Settlement With SEC

US Subsidiaries Aegon Reach Settlement With SEC

Today, US subsidiaries of Aegon reached a settlement with the Securities and Exchange Commission (SEC) in the matter of the operation and implementation of asset management quantitative models by Aegon's US asset management operations, and related...

Why Large-Cap Pharma Stocks Like Pfizer and Lilly Might Still Have Upside

Why Large-Cap Pharma Stocks Like Pfizer and Lilly Might Still Have Upside

A 'bullish perfect storm of technical factors' is powering the recent strength in large-cap pharma stocks, says Evercore ISI's Rich Ross.

Alibaba's Domestic Focus; Allergan Takes Another Lump -- ICYMI

Alibaba's Domestic Focus; Allergan Takes Another Lump -- ICYMI

Here's what you need to know now for Thursday, Aug. 23.

Allergan Has Finally Made a Base Pattern Traders Can Approach From the Long Side

Allergan Has Finally Made a Base Pattern Traders Can Approach From the Long Side

Let's check out the charts again so see how far this advance might carry.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AGN, DSS, ENDP, ICUI, PIH, SPB, SPPI, WAAS, YRD Downgrades: BMA, BRT, ELSE, FRBK, HAE, HSKA, JD, MATW, TCMD, TSG Initiations: ALT, TRTX Read on to get TheStreet Quant Ratings' detailed report:

Jim Cramer: This Is a Rotation, Not a Recession

Jim Cramer: This Is a Rotation, Not a Recession

There's too much evidence of economic strength, so don't interpret these moves as a sign of a real slowdown.

Aegon Reports Strong First Half 2018 Results

Aegon Reports Strong First Half 2018 Results

Net income amounts to EUR 491 million supported by increase in underlying earnings Underlying earnings increase by 2% to EUR 1,064 million, or 10% on constant currencies driven by expense savings, a higher investment margin in the Netherlands, performance...

Aegon To Divest Its Businesses In Czech Republic And Slovakia

Aegon To Divest Its Businesses In Czech Republic And Slovakia

Aegon has agreed to sell its businesses in Czech Republic and Slovakia for EUR 155 million to NN Group.

Here's What Was Behind Monday's Selloff

The Dow Jones Industrial Average declined by 125 points on Monday.

Aegon To Divest Last Block Of US Life Reinsurance Business

Aegon To Divest Last Block Of US Life Reinsurance Business

Aegon has agreed to divest the last substantial block of its life reinsurance business to SCOR Global Life.

Let Me Report Two of the Oddest Statistics of the Day

The first is the ISE Equity Ratio which chimed in at 213%, its first reading over 200% since January 26.

Following Up on Cimarex

So where do we go from here? We have a rule to never sell into a maelstrom.

Aegon To Divest Last Block Of US Life Reinsurance Business

Aegon To Divest Last Block Of US Life Reinsurance Business

Aegon has agreed to divest the last substantial block of its life reinsurance business to SCOR Global Life.

Biotechs: Adding to Radius Health, Flexion

Biotechs: Adding to Radius Health, Flexion

This downward action in the small biotech sector tends to happen often in the 'dog days' of summer.

Netflix and Twitter Are Among 29 Stocks Ready to Change Direction

Netflix and Twitter Are Among 29 Stocks Ready to Change Direction

These names are showing technical characteristics of either bullish or bearish reversal patterns over the past week.

TheStreet Quant Rating: D+ (Sell)